Abstract:Abstract: Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors belonging to the nuclear receptor family. PPARs function as regulators of lipid and lipoprotein metabolism and glucose homeostasis and influence cellular proliferation, differentiation and apoptosis. PPARα is highly expressed in tissues such as liver, muscle, kidney and heart, where it stimulates the β-oxidative degradation of fatty acids. PPARγ is predominantly expressed in intestine and adipose tissue. PPARγ triggers adipocyte differentiation and promotes lipid storage. The hypolipidemic fibrates and the antidiabetic glitazones are synthetic ligands for PPARα and PPARγ, respectively. Furthermore, fatty acids and eicosanoids are natural PPAR ligands: PPARα is activated by leukotriene B4, whereas prostaglandin J2 is a PPARγ ligand. These observations suggested a potential role for PPARs not only in metabolic but also in inflammation control. The first evidence for a role of PPARα in inflammation control came from the demonstration that PPARα deficient mice display a prolonged response to inflammatory stimuli. It was suggested that PPARα deficiency results in a reduced β-oxidative degradation of these inflammatory fatty acid derivatives. More recently, PPAR activators were shown to inhibit the activation of inflammatory response genes (such as IL-2, IL-6, IL-8, TNFα and metalloproteases) by negatively interfering with the NF-κB, STAT and AP-1 signalling pathways. PPAR activators exert these anti-inflammatory activities in different immunological and vascular wall cell types such as monocyte/macrophages, endothelial, epithelial and smooth muscle cells in which PPARs are expressed. These recent findings indicate a modulatory role for PPARs in the control of the inflammatory response with potential therapeutic applications in inflammation-related diseases, such as atherosclerosis and inflammatory bowel disease.

Role of PPARβ/δ in Inflammation

Peroxisome proliferator-activated receptors (PPARs): Nuclear receptors at the crossroads between lipid metabolism and inflammation

PPARs as Nuclear Receptors for Nutrient and Energy Metabolism

PPAR-δ in Vascular Pathophysiology

The global perspective on peroxisome proliferator-activated receptor (PPAR) in ectopic fat deposition: A review

[Peroxisome Proliferator-Activated Receptors and Atherosclerosis].

PPAR-δin Vascular Pathophysiology

Hepatic PPARα Function is Controlled by Polyubiquitination and Proteasome‐mediated Degradation Through the Coordinated Actions of PAQR3 and HUWE1

The roles of PPARγ and its agonists in autoimmune diseases: A comprehensive review

The role of PPARs in atherosclerosis

Posttranslational Modifications of Peroxisome Proliferator-activated Receptor γ

Modulation Of Peroxisome Proliferator-Activated Receptor Gamma (Ppar Gamma) By Conjugated Fatty Acid In Obesity And Inflammatory Bowel Disease

Peroxisome Proliferator-Activated Receptor-γ in Vascular Biology

PPAR-: A key nuclear receptor in vascular function and remodeling

The Versatile Role of Peroxisome Proliferator-Activated Receptors in Immune-Mediated Intestinal Diseases

Integrative and Systemic Approaches for Evaluating PPARβ/δ (PPARD) Function

Self-regulation of the inflammatory response by peroxisome proliferator-activated receptors

Peroxisome proliferator-activated receptors and renal diseases.

PPAR control of metabolism and cardiovascular functions

Peroxisome Proliferator–Activated Receptor-α: A Pivotal Regulator of the Gastrointestinal Tract

PPARs as Key Transcription Regulators at the Crossroads of Metabolism and Inflammation